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COVID-19 infection outcome in African American Renal Transplant recipients: Detroit Medical
Center
Background: Transplant recipients are more vulnerable to infections including COVID-19, given
their comorbidities and chronic immunosuppression. Most preliminary care series report rapid
clinical progression and higher mortality compared to the general population.
Methods: Retrospective study at Harper University Hospital - Detroit Medical Center. Twentyfive renal transplant recipients (RTR) presenting consecutively with COVID-19 symptoms and
positive NP swab PCR for SARS-CoV2 between 03/01/2020 - 05/01/2020 were included. Data on
demographics, clinical presentation, laboratory findings, management and outcomes were
collected.
Results: Patients had a median age of 56, all African American and deceased donor transplant
recipients. Most had hypertension (96%), about half (52%) had diabetes, 64% had pulmonary
disease including obstructive sleep apnea, COPD and pulmonary hypertension. Most common
presenting symptom was dyspnea (64%), followed by fever and cough (56%) and diarrhea
(56%). Half of patients had multifocal opacities on initial chest x-ray (52%). Immunosuppression
with tacrolimus and low dose prednisone was continued, while mycophenolate mofetil was
held on admission. Following institution guidelines, hydroxychloroquine was given to 32% who
met criteria for risk of severe disease, while 48% received both hydroxychloroquine and
steroids. Prophylactic anticoagulation was given to 80% of patients, while therapeutic
coagulation to 8%. Oxygen supplementation given to 60% of patients and one patient required
intubation. Three patients (12%) were admitted to intensive care, of which one expired.
Treatment with mycophenolate was reintroduced based on resolution of symptoms and
laboratory parameters.
Conclusion: COVID-19 infected RTR in this cohort had lower mortality of 4% (n=1) compared to
State-wide mortality of 10%. Clinical presentation was similar to non-immunocompromised
hosts, but diarrhea was common. Despite multiple co-morbidities and chronic
immunosuppression, our patient cohort had favorable outcome and lower mortality compared
to other series. Exact reasons for this optimal outcome are unclear.
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